Solana (SOL) is down 10% on Thursday after DeFi Development Corporation (DFDV) announced an equity line of credit agreement with RK Capital Management to raise $5 billion in sales of its shares to stack additional SOL.Solana (SOL) is down 10% on Thursday after DeFi Development Corporation (DFDV) announced an equity line of credit agreement with RK Capital Management to raise $5 billion in sales of its shares to stack additional SOL.

Solana dips 10% despite DeFi Development Corp's plan to raise $5 billion to boost SOL treasury

3 min read
  • DeFi Development Corporation revealed plans to raise up to $5 billion through an equity line to boost its Solana treasury.
  • The company earlier withdrew a Form S-3 filed with the SEC, which contained its plan to raise $1 billion to buy SOL. 
  • SOL declined 10% despite the announcement.

Solana (SOL) is down 10% on Thursday after DeFi Development Corporation (DFDV) announced an equity line of credit agreement with RK Capital Management to raise $5 billion in sales of its shares to stack additional SOL.

DeFi Dev Corp secures $5 billion equity line in bid to boost SOL acquisition

Nasdaq-listed DeFi Development Corp is set to bolster its Solana treasury strategy through a newly secured $5 billion equity line of credit (ELOC) with RK Capital Management, according to a press release on Thursday.

The agreement grants DeFi Dev Corp the flexibility to issue and sell shares at its discretion, although subject to certain conditions, including the filing of a resale registration statement with the US Securities and Exchange Commission (SEC).

An equity line will allow the company to gradually sell its shares during advantageous conditions rather than issuing fixed equity pricing.

“Unlike other equity offerings, an ELOC enables DeFi Development Corp. to raise capital gradually, when it’s strategically advantageous,” DeFi Development wrote in the press release. 

The move is part of DeFi Dev Corp’s broader strategy to aggressively accumulate SOL. The company stated that it will use any proceeds from the issuance and sale of shares to purchase Solana.

It also follows the company's withdrawal of a filing it submitted to the SEC in April, according to a statement on Wednesday. DeFi Dev Corp said the regulator found it ineligible to submit an S-3 filing as it failed to include a management report on internal control over financial reporting.

The company also shared that it integrated its liquid staking token (LST), dfdvSOL, into RateX, a yield trading platform built on Solana. The incorporation allows dfdvSOL to generate yield from RateX’s ecosystem, providing holders with fixed-yield products, yield trading opportunities and liquidity farming incentives.

DeFi Dev Corp currently holds 609,190 Solana, valued at $93 million at publication time. The company has made a total of 11 purchases since it began its Solana treasury strategy in April.

Following the announcement, SOL declined below the 50-day Simple Moving Average (SMA) after it saw a rejection at the upper boundary of a descending channel the previous day. As a result, SOL is down 10% over the past 24 hours and is testing the $142 support, strengthened by the 100-day SMA. A further decline below $142 could see SOL testing the channel's lower boundary. The decline mirrors that of Bitcoin (BTC) and the general crypto market, with several altcoins witnessing double-digit losses.

SOL/USDT daily chart

The Relative Strength Index (RSI) declined below its moving average and neutral level while the Stochastic Oscillator (Stoch) is in the oversold region, indicating strong bearish pressure.


Market Opportunity
Solana Logo
Solana Price(SOL)
$98.04
$98.04$98.04
-4.43%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29